Burning rock announces us$10 million share repurchase program

Guangzhou, china, june 21, 2022 (globe newswire) -- burning rock biotech limited (nasdaq: bnr, the “company” or “burning rock”), a company focused on the application of next generation sequencing (ngs) technology in the field of precision oncology, today announced that its board of directors has authorized a share repurchase plan under which the company may repurchase its class a ordinary shares in the form of american depositary shares (“adss”) with an aggregate value of up to us$10 million during a 12-month period (the “share repurchase program”).
BNR Ratings Summary
BNR Quant Ranking